DH-348

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDH-348
Drug Alias NameDTP-348DH-348
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCarbonic anhydrases inhibitors
TargetsCarbonic anhydrases
Therapy Area/IndicationsSolid tumoursHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesStichting Maastricht Radiation Oncology Maastro-Clinic
China Registration ClassN/A

Develop Information

Active CompaniesStichting Maastricht Radiation Oncology Maastro-Clinic
Inactive CompaniesN/A
Active IndicationsHead and Neck Neoplasms
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A